Edition:
United Kingdom

AmerisourceBergen Corp (ABC.N)

ABC.N on New York Stock Exchange

78.97USD
14 Dec 2018
Change (% chg)

$-2.92 (-3.57%)
Prev Close
$81.89
Open
$80.78
Day's High
$81.29
Day's Low
$78.77
Volume
329,252
Avg. Vol
277,966
52-wk High
$106.26
52-wk Low
$77.34

Latest Key Developments (Source: Significant Developments)

Amerisourcebergen Names James Cleary, Jr. As CFO
Monday, 10 Sep 2018 

Sept 10 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN ANNOUNCES FINANCIAL LEADERSHIP CHANGE.CFO TIM G. GUTTMAN TO RETIRE FROM COMPANY.GROUP PRESIDENT JAMES F. CLEARY, JR. NAMED CFO.COMPANY REAFFIRMS FISCAL YEAR 2018 GUIDANCE.AMERISOURCEBERGEN - GUTTMAN WILL STEP DOWN AS CFO ON NOVEMBER 9 AND CONTINUE IN AN ADVISORY CAPACITY FURTHER INTO FISCAL YEAR 2019.FY2018 EARNINGS PER SHARE VIEW $6.48, REVENUE VIEW $167.99 BILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Amerisourcebergen Provides Update On Unit Pharmedium's 503B Compounding Facility In Memphis, Tennessee
Wednesday, 5 Sep 2018 

Sept 5 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN SAYS PROVIDES UPDATE REGARDING SUBSIDIARY PHARMEDIUM'S 503B COMPOUNDING FACILITY LOCATED IN MEMPHIS, TENNESSEE.AMERISOURCEBERGEN SAYS THIRD-PARTY CURRENT GOOD MANUFACTURING PRACTICES EXPERTS' MEMPHIS FACILITY AUDIT REPORT WAS SUBMITTED TO FDA ON SEPT. 5 - SEC FILING.AMERISOURCEBERGEN - PHARMEDIUM IS SCHEDULED TO SUBMIT ITS EVALUATION OF THE AUDIT REPORT AND ITS PLANNED ACTIONS WITH RESPECT THERETO ON SEPT. 6.AMERISOURCEBERGEN - PHARMEDIUM TO CONTINUE LIMITED PRODUCTION &,ABSENT FURTHER FEEDBACK FROM FDA, EXPECTS TO COMMENCE COMMERCIAL DISTRIBUTION IN 2018.AMERISOURCEBERGEN - ALL PREVIOUSLY COMMUNICATED ASPECTS OF CO'S FISCAL YEAR 2018 FINANCIAL GUIDANCE & ASSUMPTIONS REMAIN THE SAME.FY2018 EARNINGS PER SHARE VIEW $6.48, REVENUE VIEW $168.01 BILLION -- THOMSON REUTERS I/B/E/S.AMERISOURCEBERGEN - AFTER RESUMING COMMERCIAL DISTRIBUTION, CONTINUES TO EXPECT PRODUCTION IN MEMPHIS TO BE FULLY OPERATIONAL IN 2019.  Full Article

AmerisourceBergen Reports Fiscal Q3 Results
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN REPORTS FISCAL 2018 THIRD QUARTER RESULTS.REVENUES OF $43.1 BILLION FOR Q3, AN 11.5 PERCENT INCREASE YEAR-OVER-YEAR.Q3 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.54 EXCLUDING ITEMS.Q3 GAAP EARNINGS PER SHARE $1.25.Q3 EARNINGS PER SHARE VIEW $1.46 -- THOMSON REUTERS I/B/E/S.AMERISOURCEBERGEN - CONTINUES TO EXPECT ADJUSTED EARNINGS PER SHARE FOR FISCAL YEAR 2018 TO BE NEAR BOTTOM OF ITS GUIDANCE RANGE OF $6.45 TO $6.65.AMERISOURCEBERGEN - "AS AN UPDATE ON PHARMEDIUM, WE NOTIFIED THE FDA TWO WEEKS AGO THAT WE WERE RESUMING LIMITED PRODUCTION AT THE MEMPHIS FACILITY".AMERISOURCEBERGEN - "CONTINUE TO EXPECT PRODUCTION IN MEMPHIS TO INCREASE GRADUALLY OVER TIME AND BE FULLY OPERATIONAL IN FISCAL 2019".Q3 REVENUE VIEW $42.91 BILLION -- THOMSON REUTERS I/B/E/S.FY2018 EARNINGS PER SHARE VIEW $6.48 -- THOMSON REUTERS I/B/E/S.  Full Article

AmerisourceBergen Reports Q2 Earnings Per Share $1.29
Wednesday, 2 May 2018 

May 2 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN REPORTS FISCAL 2018 SECOND QUARTER RESULTS.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $6.45 TO $6.65.Q2 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.94 EXCLUDING ITEMS.Q2 GAAP EARNINGS PER SHARE $1.29.Q2 EARNINGS PER SHARE VIEW $1.82 -- THOMSON REUTERS I/B/E/S.NOW BELIEVES ADJUSTED DILUTED EPS FOR FISCAL YEAR 2018 WILL BE AT BOTTOM OF ITS GUIDANCE RANGE OF $6.45 TO $6.65.SEES FISCAL YEAR 2018 REVENUE GROWTH IN RANGE OF 8 PERCENT TO 11 PERCENT ON AN ADJUSTED BASIS.REVENUES OF $41.0 BILLION FOR THE SECOND QUARTER, A 10.5 PERCENT INCREASE.Q2 REVENUE VIEW $40.64 BILLION -- THOMSON REUTERS I/B/E/S.SEES FISCAL YEAR 2018 ADJUSTED OPERATING INCOME GROWTH TO BE FLAT.FY2018 EARNINGS PER SHARE VIEW $6.53, REVENUE VIEW $167.48 BILLION -- THOMSON REUTERS I/B/E/S.AMERISOURCEBERGEN - LOWER THAN PREVIOUSLY ANTICIPATED OPERATING INCOME CONTRIBUTIONS FROM PHARMEDIUM & LASH GROUP LED TO UPDATED FY 2018 GUIDANCE.  Full Article

AmerisourceBergen Anticipates Operations At Memphis Facility Will Resume This Quarter
Tuesday, 6 Feb 2018 

Feb 6 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN CORP CFO SAYS MEMPHIS FACILITY REMAINS CLOSED AND CURRENTLY ANTICIPATE OPERATIONS WILL RESUME THIS QUARTER - CONF CALL.AMERISOURCEBERGEN CORP CFO SAYS WE WERE PREVIOUSLY OPTIMISTIC THAT MEMPHIS OPERATIONS WOULD RESTART IN EARLY JANUARY - CONF CALL.AMERISOURCEBERGEN CORP CFO SAYS SEES 2018 PHARMACEUTICAL DISTRIBUTION SERVICES REVENUE GROWTH OF 1% TO 4%, REDUCED TO REFLECT IMPACT FROM PHARMEDIUM - CONF CALL.  Full Article

AmerisourceBergen Corp Says CEO Steven Collis' FY 2017 Total Compensation Was $9.9 Mln Vs $10.0 Mln In FY 2016
Friday, 19 Jan 2018 

Jan 19 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN CORP SAYS CEO STEVEN COLLIS' FY 2017 TOTAL COMPENSATION WAS $9.9 MILLION VERSUS $10.0 MILLION IN FY 2016 - SEC FILING.  Full Article

AmerisourceBergen Announces Operating Commitments to Address Opioid Diversion And Abuse
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - Amerisourcebergen Corp ::AMERISOURCEBERGEN ANNOUNCES OPERATING COMMITMENTS TO ADDRESS OPIOID DIVERSION AND ABUSE.AMERISOURCEBERGEN - WILL CONTINUE TO REPORT QUANTITY, RECEIVING PHARMACY OF ALL ORDERS OF OPIOID-BASED MEDICINES TO DRUG ENFORCEMENT AGENCY ON DAILY BASIS.  Full Article

AmerisourceBergen Prices $750 Mln 3.45 Pct Senior Notes Due 2027
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN PRICES $750 MILLION 3.45% SENIOR NOTES DUE 2027 AND $500 MILLION 4.30% SENIOR NOTES DUE 2047.  Full Article

AmerisourceBergen to acquire H. D. Smith
Monday, 20 Nov 2017 

Nov 20 (Reuters) - AmerisourceBergen Corp ::AmerisourceBergen to acquire H. D. Smith.AmerisourceBergen Corp - deal for ‍$815 million in cash​.AmerisourceBergen Corp - ‍plans to fund acquisition through issuance of new long-term debt​.AmerisourceBergen Corp - ‍acquisition is expected to be slightly accretive to adjusted diluted EPS in fiscal year 2018​.AmerisourceBergen Corp - ‍acquisition expected to achieve full run-rate synergies, be about $0.15 accretive to adjusted EPS in FY 2020​.AmerisourceBergen Corp - ‍company now expects fiscal year 2018 adjusted operating income growth to be in range of 4 percent to 7 percent​.AmerisourceBergen Corp - now sees revenue growth to be in range of 8 percent to 11 percent​ for fiscal year 2018.AmerisourceBergen Corp - ‍reaffirming rest of previously announced fiscal 2018 financial guidance​.AmerisourceBergen - expects fiscal year 2018 pharmaceutical distribution services segment operating income growth in range of 4 percent to 7 percent​.  Full Article

AmerisourceBergen increases dividend 4 percent
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Amerisourcebergen Corp ::Increases dividend 4 percent.Increased company's quarterly dividend rate 4 percent to $0.38 per common share from $0.365 per common share​​.  Full Article

UPDATE 4-AmerisourceBergen to pay $625 mln in U.S. civil fraud settlement

NEW YORK, Oct 1 AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, will pay $625 million to resolve civil fraud charges over the sale of syringes containing drugs for cancer patients, double billing, and providing kickbacks to doctors.